merck & co. mrk rose <NUM> percent to dollar <NUM> in premarket dealings after the u.s. food and drug administration said it needed more time to evaluate the safety of a diabetes drug from switzerland s novartis <PUNC>
the oral diabetes drug <COMMA> known as galvus <COMMA> would be a direct competitor for merck s diabetes treatment januvia <COMMA> which received fda approval last month <PUNC>
<PAR>
